Br J Pharmacol 179(4):659676 Hernandez AF, Green JB, Janmohamed S, DAgostino Sr RB, Granger CB, Jones NP, et al (2018) Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial
Studied for its impact on metabolic and endocrine functions, especially glucose control and appetite regulation
Saxenda (liraglutide): Approved for chronic weight management
Research Implications for India & Mumbai Ideal for studying obesity, metabolic syndrome, and NAFLD in Indian populations
I see the same team every time, they know my name, and they're invested in my progress. Verified patient Fox Valley IL Clinical information GLP-1 medications & safety What we prescribe, how we titrate, and when we may need to pause or adjust your plan
It can be prescribed to adults with obesity who have a body mass index (BMI) of 30 or above, or who are overweight with a BMI between 27 and 30 and at least one weight-related comorbidity, and should be used alongside a reduced-calorie diet and increased physical activity
